Catalyst Wire Dossier Catalyst Wire Dossier

Bexarotene with Narrow-Band UVB

bexarotene
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bexarotene with Narrow-Band UVB, covering 2008-08-07 to 2008-08-07. Get the full timeline:

Most recent: Clinical Trial Update: Bexarotene With Narrow-Band UVB for Psoriasis [Phase 2]

See pricing